Literature DB >> 17882433

[Blindness in Germany: dimensions and perspectives].

R P Finger1.   

Abstract

Blindness and visual impairment in Germany and the Western world will increase further over the coming years and decades. This is primarily due to current demographic trends leading to increased visual impairment, mainly in the elderly. In Germany the current situation of the blind and visually impaired is less well documented than in other European countries. The impact of this development can be differentiated into individual and societal dimensions, of which quality of life, morbidity, mortality, and cost are the best-documented aspects. Because of the socioeconomic and cultural importance of vision in Western society, the negative effects of an increase in blindness and visual impairment in a continuously aging population are considerable. Healthcare policy makers need to consider this when discussing future planning and resource allocation. Preventive and rehabilitative services should be given a much higher priority.

Entities:  

Mesh:

Year:  2007        PMID: 17882433     DOI: 10.1007/s00347-007-1600-3

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  28 in total

1.  Incidence of blindness in southern Germany between 1990 and 1998.

Authors:  C Trautner; B Haastert; G Giani; M Berger
Journal:  Diabetologia       Date:  2001-02       Impact factor: 10.122

Review 2.  Age-related macular degeneration and depression: a review of recent research.

Authors:  Robin J Casten; Barry W Rovner; William Tasman
Journal:  Curr Opin Ophthalmol       Date:  2004-06       Impact factor: 3.761

3.  Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study.

Authors:  C C Klaver; R C Wolfs; J R Vingerling; A Hofman; P T de Jong
Journal:  Arch Ophthalmol       Date:  1998-05

4.  Impact of severity and bilaterality of visual impairment on health-related quality of life.

Authors:  Rohit Varma; Joanne Wu; Kelly Chong; Stanley P Azen; Ron D Hays
Journal:  Ophthalmology       Date:  2006-08-04       Impact factor: 12.079

5.  [Causes of blindness in Hessia in 1996].

Authors:  M Gräf; E Halbach; H Kaufmann
Journal:  Klin Monbl Augenheilkd       Date:  1999-07       Impact factor: 0.700

6.  [Reading ability and need for reading aids, inadequate management of a nursing home population].

Authors:  B Sadowski; A Grüb; S Trauzettel-Klosinski
Journal:  Klin Monbl Augenheilkd       Date:  2000-11       Impact factor: 0.700

Review 7.  [Blindness in Germany--today and in 2030].

Authors:  C Knauer; N Pfeiffer
Journal:  Ophthalmologe       Date:  2006-09       Impact factor: 1.059

8.  [Social costs of visual handicap and blindness. Rehabilitation resources for blind patients].

Authors:  H G Krumpaszky; V Klauss; G Kloske
Journal:  Klin Monbl Augenheilkd       Date:  1992-12       Impact factor: 0.700

9.  Blindness, low vision, and other handicaps as risk factors attached to institutional residence.

Authors:  A P Brézin; A Lafuma; F Fagnani; M Mesbah; G Berdeaux
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

10.  Evaluation of non-medical costs associated with visual impairment in four European countries: France, Italy, Germany and the UK.

Authors:  Antoine Lafuma; Antoine Brézin; Stefania Lopatriello; Klaus Hieke; Julia Hutchinson; Viviane Mimaud; Gilles Berdeaux
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

View more
  9 in total

1.  [Epidemiology of severe visual impairment and blindness of old people in Germany].

Authors:  M M Mauschitz; J Q Li; P P Larsen; J Köberlein-Neu; F G Holz; M M B Breteler; R P Finger
Journal:  Ophthalmologe       Date:  2019-02       Impact factor: 1.059

2.  [Ophthalmological health care of the institutionalized elderly : The OVIS study].

Authors:  P P Fang; A Schnetzer; D G Kupitz; A P Göbel; T Kohnen; T Reinhard; B Lorenz; H Hoerauf; L Wagenfeld; G Auffarth; F Schaub; H Thieme; B von Livonius; F Alten; A Robering; C Brandl; F Ziemssen; F Krummenauer; F G Holz; R P Finger
Journal:  Ophthalmologe       Date:  2017-09       Impact factor: 1.059

3.  [Methods for estimating personal costs of disease using retinal diseases as an example].

Authors:  G Porz; H P N Scholl; F G Holz; R P Finger
Journal:  Ophthalmologe       Date:  2010-03       Impact factor: 1.059

4.  [Blindness in Germany - comparison between retrospective data and predictions for the future].

Authors:  K Rohrschneider
Journal:  Ophthalmologe       Date:  2012-04       Impact factor: 1.059

5.  Blindness and visual impairment in Germany: a slight fall in prevalence.

Authors:  Robert P Finger; Bernd Bertram; Christian Wolfram; Frank G Holz
Journal:  Dtsch Arztebl Int       Date:  2012-07-09       Impact factor: 5.594

6.  [Access to healthcare services for elderly patients with neovascular age-related macular degeneration].

Authors:  R P Finger; F G Holz
Journal:  Ophthalmologe       Date:  2012-05       Impact factor: 1.059

7.  The Prevalence of Visual Impairment in Retirement Home Residents.

Authors:  Luisa Thederan; Susanne Steinmetz; Sabine Kampmann; Anna-Maria Koob-Matthes; Franz Grehn; Thomas Klink
Journal:  Dtsch Arztebl Int       Date:  2016-05-06       Impact factor: 5.594

8.  The Prevalence of Undiagnosed Age-Related Sight-Threatening Diseases in Self-Proclaimed Healthy Individuals.

Authors:  Sophie Lemmens; João Barbosa Breda; Karel Van Keer; Tine Jacobs; Ruben Van Landeghem; Patrick De Boever; Ingeborg Stalmans
Journal:  J Ophthalmol       Date:  2020-11-07       Impact factor: 1.909

9.  Visual rehabilitation of patients with corneal diseases.

Authors:  Michael Oeverhaus; Dirk Dekowski; Herbert Hirche; Joachim Esser; Barbara Schaperdoth-Gerlings; Anja Eckstein
Journal:  BMC Ophthalmol       Date:  2020-05-06       Impact factor: 2.209

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.